Unilateral Extragenital Lichen Sclerosus Following Blaschko's Lines Authors: Li Wu, Huiying Wang, Ruzhi Zhang Published: 2024 ABSTRACT ABSTRACTLichen sclerosus is a chronic, immune‐mediated dermatologic disorder primarily affecting the genital skin. Extragenital lichen sclerosus is rare, especially in men. We present a case of ELS in a 23‐year‐old male with lesions on the left upper extremity that had persisted for seven years. Over time, the lesions gradually spread to the left upper arm and scapular region. These lesions followed a band‐like distribution along Blaschko’s lines, without associated pruritus or pain. This unusual presentation posed a diagnostic challenge, highlighting the rarity of such manifestations. Summary We present a case of extragenital lichen sclerosus in a 23‐year‐old male with lesions on the left upper extremity persisting for 7 years.The progression, without pruritus or pain, displayed a distinctive unilateral distribution along Blaschko's lines.This unusual presentation posed a diagnostic challenge, highlighting the rarity of such manifestations. Summary We present a case of extragenital lichen sclerosus in a 23‐year‐old male with lesions on the left upper extremity persisting for 7 years.The progression, without pruritus or pain, displayed a distinctive unilateral distribution along Blaschko's lines.This unusual presentation posed a diagnostic challenge, highlighting the rarity of such manifestations. We present a case of extragenital lichen sclerosus in a 23‐year‐old male with lesions on the left upper extremity persisting for 7 years. We present a case of extragenital lichen sclerosus in a 23‐year‐old male with lesions on the left upper extremity persisting for 7 years. The progression, without pruritus or pain, displayed a distinctive unilateral distribution along Blaschko's lines. The progression, without pruritus or pain, displayed a distinctive unilateral distribution along Blaschko's lines. This unusual presentation posed a diagnostic challenge, highlighting the rarity of such manifestations. This unusual presentation posed a diagnostic challenge, highlighting the rarity of such manifestations. Introduction Lichen sclerosus (LS) is a chronic mucocutaneous immune‐mediated disease that primarily affects the skin of the genital area. The pathogenesis of the disease is thought to be due to a combination of genetic, infectious, autoimmune, hormonal and environmental factors [1]. LS lesions typically present as flat, ivory‐colored, waxy spots that may merge to form thin, crinkled, or hyperkeratotic patches. Adjacent erythema and the Koebner phenomenon may also be observed. They can affect any area of the skin or mucosa, though extragenital lesions are relatively uncommon [2]. Extragenital manifestations of LS, though uncommon, occur predominantly in females, with a female‐to‐male ratio ranging from 6:1 to 10:1 [2]. These manifestations can be categorized by location, extent, and morphology of the lesions. Lesions may be localized, affecting small areas such as the upper trunk, or more extensive, involving large regions or multiple sites [1]. Guttate and plaque‐type LS are most commonly observed, while linear, zosteriform, Blaschkoid, and other variants are less frequently reported [1]. Here we present a case of extragenital lichen sclerosus in a male patient with lesions located on the left upper extremity, and exhibiting a distinctive unilateral distribution pattern along the Blaschko lines, a relatively rare presentation that presented a diagnostic challenge. Case History/Examination A 23‐year‐old man presented with punctate and patchy white sclerotic lesions on his left forearm, first noticed 7 years ago. He reported no associated symptoms such as itching, pain, or discomfort. Over time, the lesions gradually expanded to involve the left upper arm (Figure 1a). Approximately 2 months ago, similar irregularly shaped white plaques appeared on the left scapular region. Some of these plaques had faint brownish areas, creating a parchment‐like appearance with mild surface scaling (Figure 1b). Collectively, these lesions exhibited a band‐like distribution consistent with the pattern observed along the Blaschko's lines. Notably, there were no abnormalities in the external genitalia or oral mucosa. The patient had no relevant medical or family history. (a) Punctate and patchy white sclerotic patches on the left forearm, extending to the upper arm. (b) Irregularly shaped porcelain white plaques on the left scapular region. Some areas showed faint brownish patches, resembling parchment with mild skin scaling. Fungal examination and Wood's lamp assessment yielded unremarkable results, and other laboratory tests showed no abnormalities. After thorough discussion and obtaining the patient's informed consent, a biopsy was performed on the white and faint brownish patches in the left scapular region. The results revealed follicular plugging overlying a thinned out epidermis with vacuolar alteration of basal cell layer and homogeneous alteration of superficial dermal collagen (Figure 2a). Additionally, there was marked infiltration of lymphocytes and histiocytes between the dermal blood vessels and collagen (Figure 2b). (a) Histopathological examination showed epidermal atrophy, thinning of the granular layer, follicular plugging, vacuolar degeneration of basal cells, and homogeneous alteration of dermal collagen (H&E, 100×). (b) Infiltration of lymphocytes and histiocytes was observed between dermal blood vessels and collagen (H&E, 200×). Methods The differential diagnosis for this patient included vitiligo and lichen striatus. Based on the clinical and histopathological findings, a diagnosis of extragenital lichen sclerosus was confirmed. The treatment regimen included oral prednisone at 15 mg per day, along with topical 0.03% tacrolimus. After 2 weeks, the corticosteroid dosage was gradually tapered. Conclusion and Results At the 1‐month follow‐up, the lesions showed no further progression. Given the chronic nature of this condition, the patient remains under continued follow‐up care. Discussion Extragenital lichen sclerosus (ELS) typically presents as asymptomatic, white, opalescent papules that cluster and progress to plaques, eventually giving the skin a parchment‐like appearance. This condition commonly affects the submammary area, neck, shoulders, inner thighs, wrists and upper back [2]. They can occur concurrently with genital form, but in 6% of cases, it presents exclusively in the extragenital region [1]. Additionally, a rare variant is linear ELS adherent to Blaschko's lines, which presents as a rare manifestation of lichen sclerosus (LS). Only a few cases have been documented in the literature, and no cases of unilateral ELS extending from the forearm to the scapula have been reported [3, 4, 5]. Blaschko's lines, first described by Alfred Blaschko in 1901, have played a pivotal role in elucidating the clinical patterns associated with hypopigmentation and hyperpigmentation disorders [6, 7]. They form a V‐shaped pattern on the anterior neck, an M‐shape on the chest, back, waist, and buttocks, and a large M‐shape extending from the shoulders and back toward the upper limbs. On the abdomen, they appear as S‐shaped patterns along the midline, while in the occipital region, they display a whorled arrangement. On the limbs, Blaschko's lines generally follow the long axis of the extremities [8]. These discernible distributions differ from conventional patterns associated with blood vessels, lymph nodes, nerves or skin tension lines. Instead, they appear to faithfully reflect the trajectory of cellular cloning and differentiation during embryonic development [9]. Although the exact etiology of ELS remains unknown, understanding Blaschko's lines may offer unique insights into this disease's pathogenesis. The diagnosis of linear hypopigmentation poses a challenge in clinical practice. Hypopigmented streaks and swirls, following Blaschko's lines, can appear anywhere on the skin, ranging from localized unilateral to widespread bilateral involvement. Differential diagnoses for hypopigmentation along Blaschko's lines include hypomelanosis of Ito, lichen striatus, and segmental vitiligo [10]. In addition, conditions such as hypopigmented mycosis fungoides and atrophic lichen planus may also manifest with hypopigmented lesions, which should be considered in the differential diagnosis of late‐stage hypopigmented ELS lesions [2]. The diagnosis of ELS is primarily based on clinical assessment and confirmed through histopathology. Complementary diagnostic tools, such as dermoscopy, Wood's lamp examination, and fungal testing, are useful in excluding alternative diagnoses. Currently, there is no specific treatment for ELS. First‐line therapy typically involves ultra‐potent topical corticosteroids. Other topical treatments that have been explored include calcineurin inhibitors, vitamin D derivatives, and topical retinoids. Tacrolimus can serve as a second‐line option for long‐term use after corticosteroids are tapered, although it is less effective than corticosteroids [1]. Additionally, treatments such as phototherapy, surgical excision, adipose‐derived stem cells (ADSC), platelet‐rich plasma (PRP), carbon dioxide laser, pulse dye laser, and low‐dose ultraviolet (UV‐A1) phototherapy have been attempted [1]. In our patient, who experienced rapid disease progression, a combination of low‐dose oral corticosteroids and topical calcineurin inhibitors was administered. This approach successfully controlled lesion progression, though the long‐term efficacy of these treatments remains uncertain and will be assessed through follow‐up. Given the chronic nature of ELS, with potential residual scarring and pigmentary abnormalities, there is also a risk of developing subsequent genital LS, which can carry a risk of malignancy over time [1]. By presenting this unique case, we aim to contribute to the understanding and management of ELS lesions that follow Blaschko's lines in clinical practice. Author Contributions Li Wu: writing – original draft. Huiying Wang: writing – review and editing. Ruzhi Zhang: writing – review and editing. Consent Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy. Conflicts of Interest The authors declare no conflicts of interest.